FDA Biologics (BLA & Biosimilars)Original article
Annual Patient Engagement & Regenerative Medicine Meeting 2022: An FDA CBER Workshop for Patient Advocates - 05/24/2022
ConferenceNeutral
AI Analysis
Summary
FDA CBER announces an annual patient engagement and regenerative medicine workshop scheduled for May 24, 2022. The event is designed for patient advocates and aims to promote patient participation in regenerative medicine initiatives.
Importance:1/10
Sentiment:
0.00
patient engagementregenerative medicineFDA workshopCBER
Related Companies
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 10, 2026 3:06 PM